menu ☰
menu ˟

Bioventus receives FDA approval for hyaluronic acid injectable knee OA product

05 Sep 2017
Bioventus announced it has received FDA approval for Durolane, a single-injection hyaluronic acid product for joint lubrication in the treatment of pain associated with knee osteoarthritis.According to a company press release, Bioventus currently mar...

Click here to view the full article which appeared in Rheumatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.